OncologyTube Professional - Patients Click Here
654,213 video views
onclivetv: Videos
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, discusses biomarker results from the AURA study of AZD9291. More at http://oncli...
by:onclivetv | 877 views
Lorraine Pelosof, MD, PhD, assistant professor, Division of Hematology/Onco​logy, The University of Texas Southwestern Medical Center, discusses a study looking at the incidence of never smokers diagnosed with non-small cell lung cancer (NSCLC). More at http://oncli...
by:onclivetv | 684 views
Barbara J. Gitlitz, MD, associate professor of clinical medicine, Keck School of Medicine, University of Southern California, discusses results and key takeaways from The Genomics of Young Lung Cancer Study. More at http://oncli...
by:onclivetv | 565 views
Everett E. Vokes, MD, chair, Department of Medicine, investigator of head and neck and lung cancer, University of Chicago, discusses a plenary session that covered prevention and screening at the 16th World Conference on Lung Cancer. More at http://oncli...
by:onclivetv | 428 views
Ramaswamy Govindan, MD, medical oncologist, Washington University School of Medicine in St. Louis, discusses a talk given at the 16th World Conference on Lung Cancer. More at http://oncli...
by:onclivetv | 956 views
The value of vaccines in the prevention of cervical cancer. Thomas Herzog, MD; Bradley J. Monk, MD; and Robert L. Coleman, MD,
by:onclivetv | 559 views
Dr. Yee discusses the research that led to the FDA approval of neoadjuvant pertuzumab as part of a combination regimen for patients with HER2-positive breast cancer. Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplantation, Department of Medicine, medical on...
by:onclivetv | 880 views
Laura Jones report on FDA breakthrough designation for dabrafenib/tram​etinib in non-small cell lung cancer, legal movement regarding the first FDA-approved biosimilar, and reports on the FDA approval of carfilzomib in myeloma and sonidegib for skin cancer.
by:onclivetv | 414 views
Laura Jones an the approval of gefitinib for EGFR-mutant lung cancer, results from a phase II study of atezolizumab in bladder cancer, and new treatment advancements in multiple myeloma.
by:onclivetv | 717 views
Dr. Verma discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer. Sunil Verma, MD, MSEd, FRCPC, medical director, Louise Temerty Breast Cancer Centre at Sunnybrook Health Sciences Centre,
by:onclivetv | 564 views